GLUCOSE HEALTH, INC.

Profile

Company Names

GLUCOSE HEALTH, INC.

Addresses

609 SW 8TH STREET, SUITE 600, BENTONVILLE, AR 72712

609 SW 8TH STREET, SUITE 600, BENTONVILLE, AR 72712

Phone Numbers

479-802-3827

 

Entity Type:

CORPORATION

Industry:

MANUFACTURING

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$2,255,000.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2026-06-25 
$60,000.00 
$120,000.00 
$60,000.00 
Equity 
7
2026-01-27 
$100,000.00 
$100,000.00 
$0.00 
Equity 
6
2025-11-24 
$20,000.00 
$20,000.00 
$0.00 
Equity 
5
2023-12-04 
$290,000.00 
$290,000.00 
$0.00 
Equity 
4
2021-02-11 
$960,000.00 
$960,000.00 
$0.00 
Equity 
3
2020-06-17 
$300,000.00 
$300,000.00 
$0.00 
Equity 
2
2020-05-01 
$65,000.00 
$65,000.00 
$0.00 
Equity 
1
2019-05-01 
$460,000.00 
$460,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDMUNC 
 
BURKE 
DIRECTOR
GLUCOSE HEALTH, INC.
EDMUND 
 
BURKE 
DIRECTOR
ALLIANCE BIOENERGY PLUS, INC.   |  GLUCOSE HEALTH, INC.
GERRY 
 
DAVID 
DIRECTOR
CELSIUS HOLDINGS, INC.   |  GLUCOSE HEALTH, INC.
JOHN 
 
FIELDLY 
DIRECTOR
CELSIUS HOLDINGS, INC.   |  GLUCOSE HEALTH, INC.
FLEMING 
 
FLEMING 
DIRECTOR
GLUCOSE HEALTH, INC.
MURRAY 
 
FLEMING 
EXECUTIVE OFFICER, DIRECTOR
NACEL ENERGY CORP   |  CROWNBUTTE WIND POWER, INC.   |  CANNA BRANDS, INC. .   |  GLUCOSE HEALTH, INC.
MARC 
 
HATCH 
EXECUTIVE OFFICER
GLUCOSE HEALTH, INC.
CHRIS 
 
JEMAPETE 
DIRECTOR
GLUCOSE HEALTH, INC.
HAL 
 
KRAVITZ 
DIRECTOR
CELSIUS HOLDINGS, INC.   |  GLUCOSE HEALTH, INC.
MARK 
 
SCHAFTLEIN 
EXECUTIVE OFFICER, DIRECTOR
NACEL ENERGY CORP   |  CROWNBUTTE WIND POWER, INC.   |  CANNA BRANDS, INC. .   |  CANNA CONSUMER GOODS, INC. .   |  CONSERVATIVE BROADCAST MEDIA + PUBLISHING, INC.   |  GLUCOSE HEALTH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-07
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2026-06-25 
2026-02-04
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2026-01-27 
2025-12-05
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2025-11-24 
2024-01-19
D/A
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2023-12-04 
2023-12-07
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2023-12-04 
2021-03-09
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2021-02-11 
2020-06-19
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2020-06-17 
2020-05-12
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2020-05-01 
2019-05-03
D
Link
MANUFACTURING 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1 - $1,000,000 
Equity 
2019-05-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#